Fda Approves Cancer Drugs Without Proof They're Extending Lives

An analysis of 54 new cancer drugs found that over the last decade the FDA allowed 74% of them on the market without proof that they extended life. Seldom was there proof of improved quality of life, either.

Topics:  fda   proof   cancer drugs   life   
BING NEWS:
  • FDA approves local company's bladder cancer drug
    A California-based immunotherapy company with local operations received good news this week that the U.S. Food and Drug Administration has approved its bladder cancer treatment drug. ImmunityBio Inc.
    04/25/2024 - 3:39 am | View Link
  • FDA Approves New Bladder Cancer Drug
    The first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to bacillus Calmette-Guérin alone.
    04/23/2024 - 3:05 am | View Link
  • FDA approves bladder cancer treatment by Culver City company
    The Food and Drug Administration on Monday approved Culver City-based ImmunityBio’s treatment for bladder cancer.
    04/22/2024 - 9:27 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News